4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0001567619-23-000320
Options or other derivatives
- Chief Development Officer acquired 138,248 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bigora Sian Chief Development Officer | 2022-12-31 | Grant or award · Restricted Stock Units | +13,851 | 356,073 | D | ||
| Bigora Sian Chief Development Officer | 2023-01-01 | Grant or award · Restricted Stock Units | +75,907 | 431,985 | D | ||
| Bigora Sian Chief Development Officer | 2023-01-01 | Grant or award · Restricted Stock Units | +48,490 | 480,475 | D | ||
Loading xslF345X03/doc1.xml…